Vaccines
Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Vaccine safety & adverse events
Safety of J&J Ad26. COV2.S vaccine: Sisonke study
SisonkeTrialReport-J&J-3b-Safety-PlosMedicine Comments: BE WARY OF CONCLUSIONS IN HEADLINES AND ABSTRACTS. Reading the abstract of this J&J Covid-19 vaccine study among South African healthcare workers leaves one with a sense of trust and confidence. The authors claim “The single-dose Ad26.CoV2.S vaccine had an acceptable safety profile supporting the continued use of this vaccine in our setting.”
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Findings on Health Issues Post-Pfizer Vaccine
Reference: Botha, Z. (2021). To whom it may concern: Herewith report on the findings of patients that had the Pfizer vaccine. [Unpublished manuscript]. Summary: The report details observations from a practitioner treating over thirty patients who experienced significant health issues following the Pfizer Covid vaccine between June and September 2021. Symptoms reported included severe headaches,
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Critical Review of COVID-19 Vaccines in Australia
Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review evaluates COVID-19 mRNA vaccines from an Australian perspective, focusing on their safety and efficacy. The authors discuss initial promises versus actual outcomes, citing serious side effects—including deaths—from collected case reports. They